Advances in biomathematical modeling for PET neuroreceptor imaging

Drug Discovery Today: Technologies

Volumn 8, Issue 2-4, 2011, Pages

  Gunn, Roger N ^a,b,c   Guo, Qi ^c   Salinas, Cristian A ^a   Tziortzi, Andri C ^d   Searle, Graham E ^a  

^a Imanova Ltd   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER; RADIOLIGAND; TRACER;

BIOMATHEMATICAL TECHNIQUE; BLOOD BRAIN BARRIER; DIFFUSION WEIGHTED IMAGING; IMAGE PROCESSING; IMAGE QUALITY; MATHEMATICAL MODEL; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW;

EID: 84861227121     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.01.001     Document Type: Review

References (58)

1. Wagner, H.N., Jr et al. (1983) Imaging dopamine receptors in the human brain by positron tomography. Science 221, 1264-1266 (Pubitemid 13001277)
2. Farde, L. et al. (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231, 258-261 (Pubitemid 16160075)
3. Townsend, D.W. (2004) Physical principles and technology of clinical PET imaging. Ann. Acad. Med. Singapore 33, 133-145 (Pubitemid 38684848)
4. Studholme, C. et al. (1997) Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med. Phys. 24, 25-35 (Pubitemid 27051930)
5. Mourik, J.E. et al. (2009) Off-line motion correction methods for multiframe PET data. Eur. J. Nucl. Med. Mol. Imaging 36, 2002-2013
6. Bloomfield, P.M. et al. (2003) The design and implementation of a motion correction scheme for neurological PET. Phys. Med. Biol. 48, 959-978 (Pubitemid 36553316)
7. Jin, X. et al. (2009) Accuracy of head motion compensation for the HRRT: comparison of methods. IEEE Nucl. Sci. Symp. Conf. Rec. (1997) 2009, 3199-3202
8. Catana, C. et al. (2011) MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner. J. Nucl. Med. 52, 154-161
9. Banati, R.B. et al. (1999) [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53, 2199-2203
10. Banati, R.B. et al. (2001) Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 12, 3439-3442 (Pubitemid 33065473)
11. Martinez, D. et al. (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II. Amphetamineinduced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23, 285-300 (Pubitemid 36307573)
12. Mawlawi, O. et al. (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 21, 1034-1057 (Pubitemid 32823740)
13. Tziortzi,A.C. et al. (2011)Imagingdopamine receptors inhumans with [11C]- (+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54, 264-277
14. Klein, A. et al. (2009) Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46, 786-802
15. Hammers, A. et al. (2003) Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 19, 224-247 (Pubitemid 36959351)
16. Heckemann, R.A. et al. (2010) Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multiatlas based anatomical segmentation. Neuroimage 51, 221-227
17. Patenaude, B. et al. (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56, 907-922
18. Tziortzi, A. et al. (2011) MR-DTI and PET multimodal imaging of dopamine release within subdivisions of basal ganglia. J. Phys.: Conf. Ser. 317, 012005
19. Kety, S.S. and Schmidt, C.F. (1948) The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J. Clin. Invest. 27, 476-483
20. Phelps, M.E. et al. (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 6, 371-388 (Pubitemid 10203423)
21. Mintun, M.A. et al. (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15, 217-227 (Pubitemid 14164735)
22. Cunningham, V. et al. (2004) Kinetic analysis of neuroreceptor binding using PET. 12-24
23. Gunn, R.N. et al. (2001) Positron emission tomography compartmental models. J. Cereb. Blood Flow Metab. 21, 635-652 (Pubitemid 32510452)
24. Cunningham, V.J. and Jones, T. (1993) Spectral analysis of dynamic PET studies. J. Cereb. Blood Flow Metab. 13, 15-23 (Pubitemid 23016599)
25. Gunn, R.N. et al. (2002) Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J. Cereb. Blood Flow Metab. 22, 1425-1439 (Pubitemid 35424927)
26. Patlak, C.S. et al. (1983) Graphical evaluation of blood-to-brain transfer constants frommultiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1-7 (Pubitemid 13129630)
27. Logan, J. et al. (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10, 740-747 (Pubitemid 20260955)
28. Cunningham, V.J. et al. (1991) Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J. Cereb. Blood Flow Metab. 11, 1-9
29. Lammertsma, A.A. et al. (1996) Comparison of methods for analysis of clinical [11C]raclopride studies. J. Cereb. Blood Flow Metab. 16, 42-52
30. Lammertsma, A.A. and Hume, S.P. (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4 (Pt 1), 153-158
31. Wu, Y. and Carson, R.E. (2002) Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 22, 1440-1452 (Pubitemid 35424928)
32. Gunn, R.N. et al. (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6, 279-287 (Pubitemid 28018717)
33. Ichise, M. et al. (2002) Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J. Cereb. Blood Flow Metab. 22, 1271-1281
34. Zhou, Y. et al. (2007) Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease. Neuroimage 36, 298-312 (Pubitemid 46710457)
35. Gunn, R.N. et al. (2011) Translational characterization of [(11)C]GSK931145, a PET ligand for the glycine transporter type 1. Synapse 65, 1319-1332
36. Asselin, M.C. et al. (2004) Parametrically defined cerebral blood vessels as non-invasive blood input functions for brain PET studies. Phys. Med. Biol. 49, 1033-1054
37. Zanotti-Fregonara, P. et al. (2011) Image-derived input function for brain PET studies: many challenges and few opportunities. J. Cereb. Blood Flow Metab. 31, 1986-1998
38. Zanotti-Fregonara, P. et al. (2011) Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28. PLoS ONE 6, e17056
39. Mourik, J.E. et al. (2009) Image-derived input functions for PET brain studies. Eur. J. Nucl. Med. Mol. Imaging 36, 463-471
40. Laruelle, M. (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 20, 423-451 (Pubitemid 30164887)
41. Bench, C.J. et al. (1993) Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-raclopride. Psychopharmacology (Berl.) 112, 308-314 (Pubitemid 23278294)
42. Lassen, N.A. et al. (1995) Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. J. Cereb. Blood Flow Metab. 15, 152-165
43. Cunningham, V.J. et al. (2010) Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited. J. Cereb. Blood Flow Metab. 30, 46-50
44. Zamuner, S. et al. (2010) Adaptive-optimal design in PET occupancy studies. Clin. Pharmacol. Ther. 87, 563-571
45. Abanades, S. et al. (2011) Prediction of repeat-dose occupancy from singledose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy. J. Cereb. Blood Flow Metab. 31, 944-952
46. Plisson, C. et al. (2009) 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET. J. Nucl. Med. 50, 2064-2072
47. Ashworth, S. et al. (2010) Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET. J. Nucl. Med. 51, 1021-1029
48. Pinborg, L.H. et al. (2007) [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage 34, 1450-1453 (Pubitemid 46201908)
49. Zhang, L. et al. (2003) Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance. J. Pharmacokinet. Pharmacodyn. 30, 387-404 (Pubitemid 38221931)
50. Derendorf, H. and Meibohm, B. (1999) Modeling of pharmacokinetic/ pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm. Res. 16, 176-185 (Pubitemid 29135119)
51. Lim, K.S. et al. (2007) Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers. Clin. Pharmacol. Ther. 81, 252-258 (Pubitemid 46174822)
52. van de Waterbeemd, H. et al. (1998) Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. 6, 151-165 (Pubitemid 29033982)
53. Laruelle, M. et al. (2003) Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. Mol. Imaging Biol. 5, 363-375 (Pubitemid 37489827)
54. Fowler, J.S. (2004) Radiotracer chemistry in 2003: better prediction needed. J. Nucl. Med. 45, 15N-58N
55. Guo, Q. et al. (2009) A biomathematical modeling approach to central nervous system radioligand discovery and development. J. Nucl. Med. 50, 1715-1723
56. Summerfield, S.G. et al. (2008) Toward an improved prediction of human in vivo brain penetration. Xenobiotica 38, 1518-1535
57. Townsend, D.W. et al. (2003) PET/CT scanners: a hardware approach to image fusion. Semin. Nucl. Med. 33, 193-204 (Pubitemid 36859498)
58. Wehrl, H.F. et al. (2010) Combined PET/MR imaging - technology and applications. Technol. Cancer Res. Treat. 9, 5-20